Evidence map›Paper›PMID 30289815›Full record

ArticleAIDS (London, England)2019

Effectiveness of a multivitamin supplementation program among HIV-infected adults in Tanzania.

Christopher R Sudfeld, Ashley Buchanan, Nzovu Ulenga, Donna Spiegelman, Expeditho Mtisi, Ellen Hertzmark, Aisa N Muya, David Sando, Ester Mungure, Mucho Mizinduko and 1 more

Open access · greenAbstract read
In one paragraph

Article in AIDS (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Anemia, Iron Status, and HIV: A Systematic Review of the Evidence.Advances in nutrition (Bethesda, Md.) · 2020
    Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Christopher R SudfeldDepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Ashley BuchananDepartment of Pharmacy Practice, College of Pharmacy, University of Rhode Island, Kingston, New York, USA.
Nzovu UlengaManagement and Development for Health, Dar es Salaam, Tanzania.
Donna SpiegelmanDepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Expeditho MtisiManagement and Development for Health, Dar es Salaam, Tanzania.
Ellen HertzmarkDepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Aisa N MuyaManagement and Development for Health, Dar es Salaam, Tanzania.
David SandoDepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Ester MungureDepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Mucho MizindukoDepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Wafaie W FawziDepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Harvard Global Health Institute · USManagement and Development for Health · TZHarvard University · USThe King's College · US

Funding

IMPLEMENTATION OF PROGRAMS FOR THE PREVENTION, CARE AND TREATMENT OF HIV/AIDS IN U2GPS001966 · PS · HARVARD SCHOOL OF PUBLIC HEALTH · PI FAWZI, WAFAIE W · 2010 to 2015
$13.0M
Training Tanzanian Researchers for HIV/AIDS Implementation ScienceD43TW009775 · FIC · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Wafaie W Fawzi, Christopher Sudfeld · 2015 to 2026
$3.0M
FIC NIH HHS D43 TW009775NCHHSTP CDC HHS U2G PS001966PEPFAR
6 · The paper itself

Abstract

objectiveThe objective of this study was to assess the effectiveness of a routine multivitamin supplementation program for adults living with HIV in Tanzania.

designWe conducted a retrospective cohort study of 67 707 adults enrolled in the Dar es Salaam HIV care and treatment program during 2004-2012.

methodsThe Dar es Salaam HIV care and treatment program intended to provide all adult patients with multivitamin supplements (vitamins B-complex, C, and E) free of charge; however, intermittent stockouts and other implementation issues did not afford universal coverage. We use Cox proportional hazard models to assess the time-varying association of multivitamin supplementation with mortality and clinical outcomes.

resultsThe study cohort contributed 41 540 and 129 315 person-years of follow-up time to the antiretroviral therapy (ART)-naive and ART-experienced analyses, respectively. Among 48 207 ART-naive adults, provision of multivitamins reduced the risk of mortality [adjusted hazard ratio (aHR): 0.69; 95% confidence interval (CI): 0.59-0.81], incident tuberculosis (TB) (aHR: 0.83; 0.76-0.91), and meeting ART eligibility criteria (aHR: 0.78; 95% CI: 0.73-0.83) after adjustment for time-varying confounding. Among 46 977 ART-experienced patients, multivitamins reduced mortality (hazard ratio: 0.86; 95% CI: 0.80-0.92), incident TB (aHR: 0.78; 95% CI: 0.73-0.84), and immunologic failure (aHR: 0.70; 95% CI: 0.67-0.73). The survival benefits associated with provision multivitamins appeared to be greatest during the first year of ART and declined over time (P value <0.001).

conclusionMultivitamin supplementation appears to be a simple, effective, safe, and scalable program to improve survival, reduce incidence of TB, and improve treatment outcomes for adult HIV patients in Tanzania.

Indexed as

AdolescentAdultAgedAged, 80 and overFemaleHIV InfectionsHumansMaleMiddle AgedRetrospective StudiesSurvival AnalysisSustained Virologic ResponseTanzaniaTreatment OutcomeTuberculosisVitaminsVitamins

Identifiers

PMID30289815
PMCPMC6599688
OpenAlexW2894842546

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.